Assignee
SCHENK DALE B
US·13 granted patents·12 pending applications·129 citations·filing 2004–2015
Top patents by PatentIndex Score
25 records- 0194US8092801B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Jan 10, 2012·44 cites·15 claims
- 0293US8147833B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Apr 3, 2012·18 cites·4 claims
- 0392US8124081B2Prevention and treatment of amyloidogenic diseasesSCHENK DALE B·Filed 2007·Granted Feb 28, 2012·12 cites·22 claims
- 0491US8506959B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2005·Granted Aug 13, 2013·13 cites·15 claims
- 0591US8404815B2Chimeric, humanized, or human antibody 2A4SCHENK DALE B·Filed 2011·Granted Mar 26, 2013·8 cites·3 claims
- 0690US8791243B2Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2008·Granted Jul 29, 2014·8 cites·17 claims
- 0790US8268973B2Anti-amyloid antibodiesSCHENK DALE B·Filed 2011·Granted Sep 18, 2012·7 cites·18 claims
- 0886US8642044B2Prevention and treatment of amyloidogenic diseaseSCHENK DALE B·Filed 2007·Granted Feb 4, 2014·4 cites·28 claims
- 0983US9034337B2Treatment and delay of outset of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2007·Granted May 19, 2015·7 cites·15 claims
- 1081US8636981B2Detection of amyloid deposits using anti-amyloid antibodiesSCHENK DALE B·Filed 2011·Granted Jan 28, 2014·2 cites·21 claims
- 1178US8741298B2APOE immunotherapySCHENK DALE B·Filed 2012·Granted Jun 3, 2014·3 cites·65 claims
- 1273US8697082B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2004·Granted Apr 15, 2014·3 cites·15 claims
- 1368US2014227274A1Prevention and Treatment of Amyloidogenic DiseaseSCHENK DALE B·Filed 2013·Application pending·0 cites
- 1467US2014134103A1Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2013·Application pending·0 cites
- 1564US8535673B2Prevention and treatment of amyloidogenic diseaseSCHENK DALE B·Filed 2004·Granted Sep 17, 2013·0 cites·11 claims
- 1664US2012321555A1Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2012·Application pending·0 cites
- 1764US2012276116A1Prevention and Treatment of Amyloidogenic DiseaseSCHENK DALE B·Filed 2011·Application pending·0 cites
- 1863US2013058869A1Prevention And Treatment Of Amyloidogenic DiseaseSCHENK DALE B·Filed 2011·Application pending·0 cites
- 1961US2005249725A1Humanized antibodies that recognize beta amyloid peptideSCHENK DALE B·Filed 2004·Application pending·0 cites
- 2059US2011182893A1Prevention and treatment of amyloidogenic diseasesSCHENK DALE B·Filed 2011·Application pending·0 cites
- 2159US2012201842A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2012·Application pending·0 cites
- 2259US2011287049A1Prevention and treatment of amyloidogenic diseasesSCHENK DALE B·Filed 2011·Application pending·0 cites
- 2357US2011306756A1Prevention and Treatment of Amyloidogenic DiseaseSCHENK DALE B·Filed 2010·Application pending·0 cites
- 2455US2012142902A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseSCHENK DALE B·Filed 2011·Application pending·0 cites
- 2547US2016184416A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseSCHENK DALE B·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →